Publikace
- Phenothiazine-Tacrine Heterodimers: Pursuing Multitarget Directed Approach in Alzheimer's Disease2021 | Publikace bez příslušnosti k fakultě
- New dual small molecules for Alzheimer's disease therapy combining histamine H-3 receptor (H3R) antagonism and calcium channels blockade with additional Cholinesterase inhibition2019 | Publikace bez příslušnosti k fakultě
- Differentiated SH-SY5Y neuroblastoma cells as a model for evaluation of nerve agent-associated neurotoxicity2023 | Farmaceutická fakulta v Hradci Králové, 1. lékařská fakulta
- Development of submicromolar 17 beta-HSD10 inhibitors and their in vitro and in vivo evaluation2023 | 1. lékařská fakulta
- Tacrine First-Phase Biotransformation and Associated Hepatotoxicity: A Possible Way to Avoid Quinone Methide Formation2023 | Farmaceutická fakulta v Hradci Králové
- Neurotoxicity evoked by organophosphates and available countermeasures2023 | Publikace bez příslušnosti k fakultě
- 7-Azaindole, 2,7-diazaindole, and 1H-pyrazole as core structures for novel anticancer agents with potential chemosensitizing properties2022 | Farmaceutická fakulta v Hradci Králové, Lékařská fakulta v Hradci Králové
- Novel D-2/5-HT receptor modulators related to cariprazine with potential implication to schizophrenia treatment2022 | Ústřední knihovna
- Pursuing the Complexity of Alzheimer's Disease: Discovery of Fluoren-9-Amines as Selective Butyrylcholinesterase Inhibitors and N-Methyl-D-Aspartate Receptor Antagonists2021 | Farmaceutická fakulta v Hradci Králové, Přírodovědecká fakulta
- 2-Propargylamino-naphthoquinone derivatives as multipotent agents for the treatment of Alzheimer's disease2021 | Publikace bez příslušnosti k fakultě
Loading network view...